Bottneuro
Basel
About Bottneuro
Bottneuro offers a unique, non-invasive therapy for early- and moderate-stage Alzheimer's Disease patients using electrical stimulations of neurons and glia cells in the brain. Bottoneuro develops stimulation protocols using the NENI technology platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.5M
- Last round: Convertible Note (Dec 2022)
- Website: bottneuro.chwp
- Phone: +41 61 633 29 50
Industries & Categories
Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/bottneuro-30822 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.